Alternating Supplementation of Aspirin and Delta-Tocotrienol Inhibited Tumor Development in a Murine Model Resembling Early-Stage Colorectal Cancer

Conclusions: Preliminary data suggest that insulin-inhibiting diets are safe and feasible for cancer patients.The induction and maintenance of ketosis correlated with disease stabilization.While KD is not considered a standalone cancer treatment, it may complement therapies like chemotherapy, radiotherapy, and targeted inhibitors.Further research is necessary to evaluate its role in cancer management.